Blockchain in Genomics Market Report 2026

The blockchain in genomics market size has grown rapidly in recent years. It will grow from $1.01 billion in 2025 to $1.2 billion in 2026 at a compound annual growth rate (CAGR) of 19.2%. The growth in the historic period can be attributed to rising demand for personalized medicine, increasing genomic data generation, adoption of cloud-based genomic platforms, growing need for secure data sharing, advancements in genomics research and sequencing technologies.

The blockchain in genomics market size is expected to see rapid growth in the next few years. It will grow to $2.35 billion in 2030 at a compound annual growth rate (CAGR) of 18.3%. The growth in the forecast period can be attributed to integration of blockchain with AI in genomics, expansion of genomic data marketplaces, increasing adoption of tokenized genomic data models, growth of b2b and b2c genomic services, rising regulatory focus on data privacy and security in genomics. Major trends in the forecast period include secure genomic data storage, blockchain-based genomic data sharing, patient consent management on blockchain, automated genomic data access control, tokenization of genomic data.

The increasing adoption of digital tools is expected to drive the growth of the blockchain in genomics market. Digital adoption refers to the integration of new digital technologies and systems to improve processes and achieve goals. The global COVID-19 pandemic acted as a major catalyst for this shift, as lockdowns and social distancing measures pushed individuals and businesses to rely on digital tools for communication, education, shopping, and entertainment. In genomics, digital tools like software, hardware, and online platforms are used in blockchain applications to enhance encryption and security, ensuring the confidentiality and protection of genomic data. For example, in May 2024, Eurostat, a Luxembourg-based government agency, reported that in 2023, 8.5% of individuals in the EU aged 16 to 74 participated in online consultations using the internet. This growing demand for digital health solutions is fueling the expansion of blockchain in genomics.

Major companies in the blockchain-in-genomics market are entering strategic collaborations to develop blockchain-based Proof of Personhood (PoP) credentials that utilize DNA testing for highly secure and sybil-resistant identity validation. For example, in February 2025, Humanity Protocol, a China-based blockchain identity verification network, partnered with Prenetics, a China-based genomics company, to integrate Prenetics’ CircleDNA service as an official Identity Validator within Humanity Protocol’s blockchain framework. This partnership merges advanced genetic testing with zero-knowledge proof technology to create privacy-focused PoP credentials designed to prevent Sybil attacks. In addition, Prenetics is building a Crypto Strategic Reserve by investing $1.5 million in digital assets - including $H tokens, Bitcoin, and Solana - to promote innovation at the intersection of blockchain, healthcare, and decentralized science. The collaboration seeks to combine genomic precision with blockchain capabilities to advance decentralized identity solutions for finance, healthcare, and governance, while ensuring strong privacy preservation. This represents a notable step forward in introducing DNA-based identity verification into Web3 and decentralized ecosystems.

In May 2024, Rymedi, a U.S.-based provider of blockchain-enabled healthcare data management platforms for diagnostic testing and clinical research, formed a partnership with Precision Genetics. The collaboration aims to enhance healthcare outcomes by integrating Precision Genetics' personalized drug response solution with Rymedi's blockchain clinical trial platform. Their goal is to reduce post-surgical drug risks and optimize recovery. This partnership will help modernize patient care and improve overall healthcare efficiency. Precision Genetics is a U.S.-based provider of genomic testing and precision medicine.

Major companies operating in the blockchain in genomics market are International Business Machines Corporation; Sharecare Inc.; WuXi Nextcode Genomics Inc.; Health Utility Network Inc.; Medicalchain Ltd.; Futura Genetics LLC; Nebula Genomics Inc.; Digital DNAtix Ltd.; EncrypGen Inc.; Longenesis; Guardtime AS; Embleema Inc.; Patientory Inc.; Shivom Ventures Limited; BurstIQ LLC; Genobank.io Inc.; LunaDNA LLC; SimplyVital Health Inc.; Zenome.io Ltd.

North America was the largest region in the blockchain in genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blockchain in genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blockchain in genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the blockchain in genomics market by increasing the cost of blockchain infrastructure and storage hardware necessary for secure genomic data platforms. This has affected segments such as blockchain platforms and utility token services, particularly in regions like North America, Europe, and Asia-Pacific where genomic research and healthcare services are prominent. While tariffs may increase deployment costs and slow adoption initially, they also encourage local innovation in blockchain infrastructure and genomic data management solutions, potentially benefiting domestic providers in the long term.

The blockchain in genomics market research report is one of a series of new reports that provides blockchain in genomics market statistics, including blockchain in genomics industry global market size, regional shares, competitors with a blockchain in genomics market share, detailed blockchain in genomics market segments, market trends and opportunities, and any further data you may need to thrive in the blockchain in genomics industry. This blockchain in genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Blockchain in genomics refers to the application of blockchain technology in the genomics field, integrating the decentralized and secure characteristics of blockchain with the storage, sharing, and analysis of genomic data. This application creates a blockchain-based platform that allows individuals to securely store and share their genomic data.

The main services within the blockchain in genomics market include utility tokens and blockchain platforms. In the context of cryptocurrency and blockchain, utility tokens are tokens with a specific use and offer utility within a particular ecosystem. The business models involved in this market encompass business-to-business (B2B), business-to-consumer (B2C), and consumer-to-business (C2B) models. These models find applications such as data sharing and monetization, data storage and security, and automated health insurance. The end users of blockchain in genomics include pharmaceutical and biotechnology companies, hospitals and healthcare providers, research institutes, data owners, and other stakeholders in the genomics ecosystem.

The blockchain in genomics market includes revenues earned by entities by providing services such as data sharing and monetization, data security and privacy and data access and management. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The blockchain in genomics market also consists of sales of genomic supply chain tracking systems, secure storage systems, internet of things (IoT) devices, and mobile devices. Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.